In this context, NC410, a dimeric LAIR2-Fc fusion protein that blocks collagen binding to LAIR1, has shown the ability to stimulate human T cell expansion in a xenogeneic graft-versus-host disease model and enhance T cell-mediated antitumor immunity in a humanized tumor model [166]. Here, LAIR1 is linked to neoplasm.